Two pharmaceutical companies are expanding the recent recalls of a variety of blood pressure medications. All of the recalls are due to the finding of N-Methylnitrosobutyric acid above the acceptable ...
High blood pressure is a serious concern, as health experts estimate it was either a “primary or contributing cause” for more than 664,000 deaths in 2023. But, as the Cleveland Clinic warns, ...
-- Product: MAR-Amlodipine 5 mg, DIN 02371715 -- Issue: Health products - Product safety -- What to do: Immediately check your bottle of MAR-Amlodipine 5 mg tablets. The correct tablets are white to ...
AurobindoPharma USA, Inc. is conducting a voluntary recall expansion of 38 lots of Valsartan and Amlodipine and Valsartan tablets to the consumer level due to the detection of trace amounts of an ...
Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level due to the ...
FDA Issues Losartan Blood Pressure Medication Recall Over Cancer Risk Doctors say patients with high blood pressure should pay attention to and be ready to act on the trickle of drug recalls involving ...
The UK Government has issued a product recall of a particular batch of particular blood pressure medicine after a packaging error occurred on a drug company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results